» Articles » PMID: 37181295

Recent Progress in Aptamer-based Microfluidics for the Detection of Circulating Tumor Cells and Extracellular Vesicles

Overview
Journal J Pharm Anal
Specialty Chemistry
Date 2023 May 14
PMID 37181295
Authors
Affiliations
Soon will be listed here.
Abstract

Liquid biopsy is a technology that exhibits potential to detect cancer early, monitor therapies, and predict cancer prognosis due to its unique characteristics, including noninvasive sampling and real-time analysis. Circulating tumor cells (CTCs) and extracellular vesicles (EVs) are two important components of circulating targets, carrying substantial disease-related molecular information and playing a key role in liquid biopsy. Aptamers are single-stranded oligonucleotides with superior affinity and specificity, and they can bind to targets by folding into unique tertiary structures. Aptamer-based microfluidic platforms offer new ways to enhance the purity and capture efficiency of CTCs and EVs by combining the advantages of microfluidic chips as isolation platforms and aptamers as recognition tools. In this review, we first briefly introduce some new strategies for aptamer discovery based on traditional and aptamer-based microfluidic approaches. Then, we subsequently summarize the progress of aptamer-based microfluidics for CTC and EV detection. Finally, we offer an outlook on the future directional challenges of aptamer-based microfluidics for circulating targets in clinical applications.

Citing Articles

Recent Advances in Aptamer-Based Microfluidic Biosensors for the Isolation, Signal Amplification and Detection of Exosomes.

Hu J, Gao D Sensors (Basel). 2025; 25(3).

PMID: 39943486 PMC: 11820184. DOI: 10.3390/s25030848.


Extracellular vesicles: from intracellular trafficking molecules to fully fortified delivery vehicles for cancer therapeutics.

Mohamed A, Abaza T, Youssef Y, Rady M, Fahmy S, Kamel R Nanoscale Adv. 2025; 7(4):934-962.

PMID: 39823046 PMC: 11733735. DOI: 10.1039/d4na00393d.


Characterization of extracellular vesicles by capillary zone electrophoresis: A novel concept for characterization of a next-generation drug delivery platform.

Stec A, Heinz A, Dziomba S J Pharm Anal. 2025; 14(12):101004.

PMID: 39802401 PMC: 11721263. DOI: 10.1016/j.jpha.2024.101004.


Advances in subpopulation separation and detection of extracellular vesicles: for liquid biopsy and downstream research.

Liu Z, Chen G, Yu Z Theranostics. 2025; 15(3):1135-1155.

PMID: 39776815 PMC: 11700854. DOI: 10.7150/thno.106459.


Applications of single-cell technologies in drug discovery for tumor treatment.

Liu B, Hu S, Wang X iScience. 2024; 27(8):110486.

PMID: 39171294 PMC: 11338156. DOI: 10.1016/j.isci.2024.110486.


References
1.
Dickey D, Giangrande P . Oligonucleotide aptamers: A next-generation technology for the capture and detection of circulating tumor cells. Methods. 2015; 97:94-103. PMC: 4792782. DOI: 10.1016/j.ymeth.2015.11.020. View

2.
Hassan E, Willmore W, DeRosa M . Aptamers: Promising Tools for the Detection of Circulating Tumor Cells. Nucleic Acid Ther. 2016; 26(6):335-347. DOI: 10.1089/nat.2016.0632. View

3.
Pan B, Teng K, Wu C, Adam M, Johnstone R . Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes. J Cell Biol. 1985; 101(3):942-8. PMC: 2113705. DOI: 10.1083/jcb.101.3.942. View

4.
Liu C, Zhao J, Tian F, Chang J, Zhang W, Sun J . λ-DNA- and Aptamer-Mediated Sorting and Analysis of Extracellular Vesicles. J Am Chem Soc. 2019; 141(9):3817-3821. DOI: 10.1021/jacs.9b00007. View

5.
Yu M, Stott S, Toner M, Maheswaran S, Haber D . Circulating tumor cells: approaches to isolation and characterization. J Cell Biol. 2011; 192(3):373-82. PMC: 3101098. DOI: 10.1083/jcb.201010021. View